About IPM.ai
IPM.ai is a Healthcare company based in Cambridge (United States) founded in 2017, and was acquired by W2O Group in January 2021. AI-powered platform optimizes rare disease therapy lifecycles. IPM.ai offers products and services including DTC Marketing Solutions, HCP Marketing Solutions, TV Marketing Solutions, Swoop Agents, and Swoop Piper. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and Signant Health; 2 of its 3 listed competitors have raised funding.
Company details
IPM.ai was founded in 2017 in Cambridge, United States, and operates within the precision medicine sector. An AI-driven platform is utilized to support the product lifecycle for rare disease therapies. Services encompass market assessment, patient identification and profiling, treatment journey mapping, healthcare professional identification, patient and HCP segmentation, referral network mapping, specialty inference, key opinion leader discovery, and HCP activation.
Products & Services of IPM.ai
IPM.ai offers a comprehensive portfolio of products and services, including DTC Marketing Solutions, HCP Marketing Solutions, TV Marketing Solutions, Swoop Agents, and Swoop Piper.
Privacy-safe tools to connect brands with consumers across channels
AI-driven strategies for healthcare providers and patient targeting
Data-driven TV campaigns to bridge audience fragmentation
Real-time insights for brand websites and user queries
Generative AI for data analysis in healthcare marketing
Condition-specific communities for patient support and insights
Apps and channels of IPM.ai
its YouTube channel Swoop has 18 subscribers and 16 videos.
Videos from IPM.ai
The most watched videos on IPM.ai's YouTube channel, Swoop (18 subscribers). Click a video to play it here.
More on Swoop.
Investors in IPM.ai
IPM.ai has secured backing from 1 investor. Prominent investors backing the company include W2O Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Marketing communications services are delivered to businesses worldwide. | 2001 | w2ogroup.com | New York, United States |
Investor details for IPM.ai
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IPM.ai
21 people are tracked at IPM.ai (13 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Cindy Smith | Chief Financial Officer | Leadership |
James Wang | Executive Director of Sales | Leadership |
Sim Simeonov | CTO & Founder | Leadership |
Paula Ferreira Albee | Vice President of Sales, Northeast | Leadership |
Eric Horowitz | Vice President, Product Innovation and RWD Patient Solutions | Leadership |
Eric Tsuchiyama | Director of Sales, West & Midwest - IPM.ai, part of Real Chemistry | Leadership |
Jared Minton | Chief Revenue Officer | Leadership |
Dan Schwartz | VP Sales, West & Midwest - IPM.ai, part of Real Chemistry | Leadership |
Erica Ivory Williams | Director of Sales, West & Midwest - IPM.ai, part of Real Chemistry | Leadership |
Megan Bochner (Halsch) | Sr. Director of Sales | Leadership |
Nitin Choudhary | Executive Vice President and General Manager | Leadership |
Shweta Nanda Kandhari | Chief Analytics Officer, RWD | Leadership |
Jim McEnaney | Director, RWE Analytics | Leadership |
Patrick Stewart | Senior Health Data Engineer | Team |
Rachel Delinger | Senior Consultant | Team |
John Cosenza | Manager, Real-world Evidence | Team |
Alysse King | Senior Health Data Engineer | Team |
Travis Zuroske | Manager - RWE Consulting | Team |
Melissa R. | Senior Data Scientist | Team |
Shalini Gupta | Senior Health Data Engineer | Team |
1 more people are available in the full profile.
Complete people profiles for IPM.ai
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IPM.ai
2 dated milestones of IPM.ai across 4 years, from founding to its latest funding, stage changes and deals.
- Founded IPM.ai is founded.
- Exit Acquired by W2O Group.
Competitors of IPM.ai
IPM.ai has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and Signant Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| signanthealth.com | 2000 | Plymouth Meeting, United States | Signant Health is engaged in providing clinical trial technology solutions. |
Detailed competitors of IPM.ai
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as IPM.ai (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ipm.Ai
Complete news archive for IPM.ai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IPM.ai
IPM.ai was founded in 2017.
IPM.ai is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
IPM.ai was founded in 2017 in Cambridge, United States, and operates within the precision medicine sector. An AI-driven platform is utilized to support the product lifecycle for rare disease therapies. Services encompass market assessment, patient identification and profiling, treatment journey mapping, healthcare professional identification, patient and HCP segmentation, referral network mapping, specialty inference, key opinion leader discovery, and HCP activation.
IPM.ai's top competitors include Medidata, Verily and Signant Health.
IPM.ai offers DTC Marketing Solutions, HCP Marketing Solutions, TV Marketing Solutions, Swoop Agents, and 2 more products and services.
IPM.ai has 1 investor. Key investors include W2O Group.
Yes. IPM.ai was acquired by W2O Group in January 2021.